Favourites   Have ideas?  Sign in / Register

Positive:   RNA ↓18   Surgery ↓9.5   T cell-based ↓7.48 «See more»   Disease: Oncology ↑8.68   Diagnosing ↑19.22   Country: Canada ↑32.97

Negative:   Bad infrastructure  0.00


Immunology segment

ACRS Aclaris Therapeutics, Inc. - Common Stock up -10.33% 10.33 + Immunology, Biopharma, Medicine


Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number
+ My List
ADTX ADiTx Therapeutics, Inc. - Common Stock -18% -18% 0 + Immunology, RNA, Medicine

+ My List
AFMD Affimed N.V. - Common Stock -7.12% down -5.43% -1.69 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock -4.95% up -7.38% 2.43 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALDX Aldeyra Therapeutics, Inc. - Common Stock -1.3% down 12.99% -14.29 + Immunology, Medicine

+ My List
ALEC Alector, Inc. - Common Stock -8% -8% 0 + Disease: Neurology/Alzheimer/Parkinson's, Immunology, Medicine


Last highlighted: #ALEC SEC report: Alector, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Alector, Inc. -- SEC File Number
+ My List
ALT Altimmune, Inc. - Common Stock -6.24% up -7.3% 1.06 + Immunology, Biopharma, Medicine


Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number
+ My List
ANAB AnaptysBio, Inc. - Common Stock -0.76% up -7.46% 6.7 + Immunology, Cancer fight, Medicine

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock -4.35% down 10.65% -15 + Cancer fight, Medicine, Immunology

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock -8.86% -8.86% 0 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
ARGX argenx SE - American Depositary Shares -5.1% up -7.41% 2.31 + Immunology, Medicine

+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares 1.67% down 8.93% -7.26 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
ATHX Athersys, Inc. - Common Stock up -9.43% 9.43 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
AUPH Aurinia Pharmaceuticals Inc - Common Shares -4.86% up -7.12% 2.26 + Pharmaceutical , Immunology, Country: Canada


Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -15.24% 15.24 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
BLCM Bellicum Pharmaceuticals, Inc. - Common Stock 1.22% down 10.07% -8.85 + Biopharma, Medicine, Immunology


Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number
+ My List
BNTX BioNTech SE - American Depositary Shares -2.97% up -12.51% 9.54 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
BTAI BioXcel Therapeutics, Inc. - Common Stock -2.32% up -8.66% 6.34 + Medicine, Immunology, Artificial Intelligence, Biopharma

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares 2.37% up -12.29% 14.66 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CABA Cabaletta Bio, Inc. - Common Stock -5.37% up -7.09% 1.72 + Gene and cell, Medicine, Immunology

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -7.46% down -7.25% -0.21 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 3.31% up -10.72% 14.03 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock -5.83% up -7.49% 1.66 + Medicine, Immunology, Pharmaceutical

+ My List
CTSO Cytosorbents Corporation - Common Stock -9.5% -9.5% 0 + Immunology, Medicine, Surgery


Last highlighted: #CTSO SEC report: Cytosorbents Corp Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Cytosorbents Corp -- SEC File Number 211074173
+ My List
CUE Cue Biopharma, Inc. - Common Stock 0.46% up -8.54% 9 + Biopharma, Immunology, Cancer fight

+ My List
DBVT DBV Technologies S.A. - American Depositary Shares -3.95% up -9.19% 5.24 + Immunology, Biopharma, Medicine


Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660
+ My List
DVAX Dynavax Technologies Corporation - Common Stock 7.11% 7.11% 0 + Immunology, Biology, Biopharma, Medicine, Vaccines


Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number
+ My List
EDSA Edesa Biotech, Inc. - Common Shares -6.81% up -7.55% 0.74 + Medicine, Biopharma, Immunology

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock 1.37% up -7.77% 9.14 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
FATE Fate Therapeutics, Inc. - Common Stock 2.91% up -7.31% 10.22 + Cancer fight, Immunology, Medicine

+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 7.3% 7.3% 0 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock -7.89% -7.89% 0 + Cancer fight, Immunology, Medicine

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -5.42% up -7.13% 1.71 + Medicine, Immunology, Cancer fight

+ My List
HGEN Humanigen, Inc. - Common Stock 3.3% up -13.66% 16.96 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -6.97% up -8.61% 1.64 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTGM HTG Molecular Diagnostics, Inc. - Common Stock 4.9% down 10.72% -5.82 + Immunology, Medicine


Last highlighted: #HTGM SEC report: HTG MOLECULAR DIAGNOSTICS, INC Statement of changes in beneficial ownership of securities
+ My List
IMNM Immunome, Inc. - Common Stock -6.44% up -7.14% 0.7 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares 1.85% down 7.12% -5.27 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IMV IMV Inc. - Common Shares -5.43% up -7.58% 2.15 + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma


Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178
+ My List
IMVT Immunovant, Inc. - Common Stock 9.62% 9.62% 0 + Medicine, Immunology


Last highlighted: #IMVT SEC report: Immunovant, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Immunovant, Inc. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock 7.06% 7.06% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -6.77% up -11.38% 4.61 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock 2.37% 2.37% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock -4.12% up -7.12% 3 + Immunology, Cancer fight, Medicine

+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock -7.43% -7.43% 0 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KZR Kezar Life Sciences, Inc. - Common Stock 7.74% 7.74% 0 + Immunology, Medicine

+ My List
MDNA Medicenna Therapeutics Corp. - Common Shares 2.67% up -12.79% 15.46 + Country: Canada, Immunology


Last highlighted: #MDNA SEC report: Medicenna Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Medicenna Therapeutics Corp. -- SEC File Number 211089394
+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock -1.72% up -9.69% 7.97 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MOR MorphoSys AG - American Depositary Shares -6.23% up -7.21% 0.98 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MRKR Marker Therapeutics, Inc. - Common Stock up -7.77% 7.77 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NLTX Neoleukin Therapeutics, Inc. - Common Stock -7.86% up -8.1% 0.24 + Medicine, Immunology


Last highlighted: #NLTX SEC report: Neoleukin Therapeutics, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Neoleukin Therapeutics, Inc. -- SEC File Number 211148247
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock -6.76% up -7.3% 0.54 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
ONCR Oncorus, Inc. - Common Stock -7.31% down -6.6% -0.71 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock up -9.52% 9.52 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares 7.28% 7.28% 0 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
PAND Pandion Therapeutics Inc. - Common stock 0.00% 0 + Immunology, Medicine, Organ transplants


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $PAND #PandionTherapeutics, Inc https://t.co/uNtZ9rhD94
+ My List
PDSB PDS Biotechnology Corporation - Common Stock -3.28% up -7.1% 3.82 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock -7% -7% 0 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -6.39% up -7.67% 1.28 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PRVB Provention Bio, Inc. - Common Stock -1.26% up -7.39% 6.13 + Immunology, Medicine


Last highlighted: #PRVB SEC report: Provention Bio, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Provention Bio, Inc. -- SEC File Number
+ My List
QDEL Quidel Corporation - Common Stock -1.95% -1.95% 0 + Medicine, Disease: Infectious, Immunology


Last highlighted: $QDEL 8-K Quidel (22 Apr, 4:53pm) 📰 Quidel Announces Preliminary Revenue for First Quarter 2021 https://t.co/LsfiDmSNca #QDEL #8K #Quidel #News
+ My List
SELB Selecta Biosciences, Inc. - Common Stock 6.27% down 8.06% -1.79 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SURF Surface Oncology, Inc. - Common Stock -4.16% up -8.05% 3.89 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock up -35.29% 35.29 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)


Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX
+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 189.49% down 189.66% -0.16999999999999 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
VIR Vir Biotechnology, Inc. - Common Stock -3.63% up -10.46% 6.83 + Immunology, Medicine


Last highlighted: #VIR SEC report: Vir Biotechnology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vir Biotechnology, Inc. -- SEC File Number 211148349
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -8.18% -8.18% 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 7.07% up 3.41% 3.66 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -7.24% down -4.83% -2.41 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.14% down -5.99% -1.15 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock -8.33% -8.33% 0 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock -6.25% up -8.75% 2.5 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
NEXI NexImmune, Inc. - Common Stock -1.32% up -10.38% 9.06 + Medicine, Immunology


Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $NEXI #NexImmune, Inc. #NexImmune, Inc https://t.co/SsyxY2SUAE
+ My List
PRTG Portage Biotech Inc. - Common Stock 8.65% up 2.77% 5.88 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock 19.22% 19.22% 0 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
SCPS Scopus BioPharma Inc. - Common Stock -6.67% up -7.33% 0.66 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.